We are live on ! Find out more
AWCI

Alpine Woods Capital Investors Portfolio holdings

AUM $460M
1-Year Est. Return 30.5%
This Fund
S&P 500
This Quarter Est. Return
+4.17%
1 Year Est. Return
+30.5%
3 Year Est. Return
+104.98%
5 Year Est. Return
+116.86%
10 Year Est. Return
+408.45%
AUM
$648M
AUM Growth
+$145M
Cap. Flow
+$186M
Cap. Flow %
28.76%
Top 10 Hldgs %
26.25%
Holding
188
New
18
Increased
69
Reduced
41
Closed
15

Top Sells

Rank Stock Value
1
VVV icon
Valvoline
VVV
+$3.03M
2
PFE icon
Pfizer
PFE
+$2.71M
3
TDW icon
Tidewater
TDW
+$2.67M
4
ORCL icon
Oracle
ORCL
+$2.58M
5
WFC icon
Wells Fargo
WFC
+$2.48M

Sector Composition

Rank Sector Weight
1 Technology 25.19%
2 Industrials 12.44%
3 Healthcare 11.33%
4 Financials 11.21%
5 Consumer Discretionary 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELV icon
76
Elevance Health
ELV
$86.6B
$2.76M 0.43%
5,092
WM icon
77
Waste Management
WM
$90.5B
$2.64M 0.41%
12,355
+5,566
+82% +$1.16M
EW icon
78
Edwards Lifesciences
EW
$53.6B
$2.63M 0.41%
28,489
+2,420
+9% +$214K
ET icon
79
Energy Transfer Partners
ET
$72.1B
$2.61M 0.4%
161,000
+75,000
+87% +$1.18M
VRTX icon
80
Vertex Pharmaceuticals
VRTX
$133B
$2.59M 0.4%
5,533
+140
+3% +$60.8K
EMR icon
81
Emerson Electric
EMR
$91.4B
$2.49M 0.38%
22,599
-4,253
-16% -$470K
DIS icon
82
Walt Disney
DIS
$178B
$2.49M 0.38%
25,039
-4,631
-16% -$499K
OKE icon
83
Oneok
OKE
$58.3B
$2.44M 0.38%
29,942
+7,722
+35% +$617K
FISV
84
Fiserv Inc
FISV
$27.4B
$2.44M 0.38%
16,375
-50
-0.3% -$7.57K
WMB icon
85
Williams Companies
WMB
$90.1B
$2.41M 0.37%
56,679
-2,870
-5% -$115K
V icon
86
Visa
V
$671B
$2.38M 0.37%
9,056
+791
+10% +$217K
LH icon
87
Labcorp
LH
$26.2B
$2.31M 0.36%
11,369
+243
+2% +$49.4K
VMC icon
88
Vulcan Materials
VMC
$36.3B
$2.24M 0.35%
9,000
CVX icon
89
Chevron
CVX
$386B
$2.22M 0.34%
14,172
+40
+0.3% +$6.38K
HESM icon
90
Hess Midstream
HESM
$5.14B
$2.08M 0.32%
57,079
+26,300
+85% +$928K
KHC icon
91
Kraft Heinz
KHC
$29.1B
$2.04M 0.31%
63,281
-7,284
-10% -$260K
GTLS
92
DELISTED
Chart Industries
GTLS
$2.01M 0.31%
13,960
-2,323
-14% -$351K
XOM icon
93
ExxonMobil
XOM
$657B
$1.99M 0.31%
17,302
DHI icon
94
D.R. Horton
DHI
$40.8B
$1.92M 0.3%
13,621
AESI icon
95
Atlas Energy Solutions
AESI
$1.47B
$1.91M 0.29%
+95,633
New +$2.13M
CME icon
96
CME Group
CME
$94.3B
$1.82M 0.28%
9,269
QCOM icon
97
Qualcomm
QCOM
$171B
$1.72M 0.26%
8,625
-65
-0.7% -$12.3K
CSCO icon
98
Cisco
CSCO
$488B
$1.69M 0.26%
35,615
-2,450
-6% -$116K
AGI icon
99
Alamos Gold
AGI
$14B
$1.68M 0.26%
107,000
C icon
100
Citigroup
C
$231B
$1.66M 0.26%
26,183
-15,000
-36% -$925K

Similar funds

Alpine Woods Capital Investors's Q2 2024 Portfolio in Review

As of Q2 2024, Alpine Woods Capital Investors held 188 positions worth $648M, up 29% from $503M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Alpine Woods Capital Investors deployed $186M of net new capital in Q2 2024, opening 18 new positions and adding to 69 existing holdings. Its largest new stake was iShares Core MSCI Total International Stock ETF: 361,000 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Valvoline, an estimated $3.03M trimmed.

  • Alpine Woods Capital Investors's largest Q2 2024 buy was iShares Core MSCI Total International Stock ETF: 361,000 shares worth $24.4M.
  • Alpine Woods Capital Investors added most to Alphabet (Google) Class C in Q2 2024, an estimated $4.02M increase.
  • Alpine Woods Capital Investors's biggest Q2 2024 reduction was Valvoline, cutting an estimated $3.03M.
  • Alpine Woods Capital Investors fully exited Pfizer in Q2 2024, selling an estimated $2.71M.
  • Alpine Woods Capital Investors's ten largest holdings make up 26% of its $648M portfolio in Q2 2024.
  • Alpine Woods Capital Investors opened 18 new positions and closed 15 in Q2 2024.
  • Alpine Woods Capital Investors's portfolio value rose 29% quarter-over-quarter to $648M.

Based on Alpine Woods Capital Investors's 13F filing for Q2 2024, filed 6 Aug 2024.